Results 31 to 40 of about 91,699 (304)
Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries [PDF]
, 2016 Background: The burden of dengue continues to increase globally, with an estimated 100 million clinically apparent infections occurring each year. Although most dengue infections are asymptomatic, patients can present with a wide spectrum of clinical ...
Ahmed, Firoz +35 more
core +2 more sources
PLoS ONE, 2022 BackgroundDengue infection is the most prevalent mosquito-borne viral infection globally. Concurrently, there has also been an upsurge of non-communicable comorbidities.
Wei Yao Ng +12 more
doaj +2 more sources
Asian Pacific Journal of Tropical Medicine, 2020 Objective: To determine the relationship between C-reactive protein (CRP) level and the severity of dengue and the potential use of CRP in predicting acute dengue infection.
Raghavendra Rao +3 more
doaj +1 more source
Dengue immunopathology: Importance and participation of monocytes and their subsets
Iatreia, 2019 Dengue is an acute viral infection transmitted by the bite of the mosquito belonging to the genus Aedes, which produce until 100 millions of infections worldwide per year.
Naranjo Gómez, Juan Sebastián +3 more
doaj +1 more source
Risk factors of severe dengue in children: A nested case-control study
Journal of Pediatric Critical Care, 2021 Background: Dengue is a mosquito-borne viral disease whose severity varies from a mild undifferentiated fever to severe fatal form. The objectives of this study were to determine the prevalence and risk factors of severe dengue.
Sridevi A Naaraayan +1 more
doaj +1 more source
Analysis of dengue cases according to clinical severity, São Luís, Maranhão, Brazil
Revista do Instituto de Medicina Tropical de São Paulo, 2017 Severe dengue cases have increased in Brazil since 2001, with the first records in Maranhão dating back to 2002. The aim of this study was to determine the prevalence of severe dengue cases by age group and the possible risk factors.
José de Jesus Dias Júnior +5 more
doaj +1 more source
Schistosoma haematobium infection and Buruli ulcer [PDF]
, 2004 No abstract ...
Aguiar, Julia +7 more
core +3 more sources
Lovastatin for adult patients with dengue: protocol for a randomised controlled trial. [PDF]
, 2012 BACKGROUND: Dengue is the most important vector-borne viral infection of man, with approximately 2 billion people living in areas at risk. Infection results in a range of manifestations from asymptomatic infection through to life-threatening shock and ...
Dung, Nguyen Thi Phuong +12 more
core +1 more source
The effects of weather and climate change on dengue [PDF]
, 2013 There is much uncertainty about the future impact of climate change on vector-borne diseases. Such uncertainty reflects the difficulties in modelling the complex interactions between disease, climatic and socioeconomic determinants.
Colón-González, Felipe J. +3 more
core +2 more sources
Wolbachia versus dengue: Evolutionary forecasts. [PDF]
, 2013 A novel form of biological control is being applied to the dengue virus. The agent is the maternally transmitted bacterium Wolbachia, naturally absent from the main dengue vector, the mosquito Aedes aegypti.
Bull, James J, Turelli, Michael
core +1 more source